| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | 212.5% | HC Wainwright & Co. | → $3 | Reiterates | Buy → Buy |
| 07/25/2023 | 212.5% | HC Wainwright & Co. | → $3 | Reiterates | Buy → Buy |
| 06/01/2023 | 212.5% | HC Wainwright & Co. | → $3 | Reiterates | Buy → Buy |
| 05/23/2023 | 212.5% | HC Wainwright & Co. | → $3 | Reiterates | Buy → Buy |
| 03/28/2023 | 212.5% | HC Wainwright & Co. | → $3 | Reiterates | → Buy |
| 03/20/2023 | 212.5% | HC Wainwright & Co. | → $3 | Initiates Coverage On | → Buy |
| 10/25/2022 | 212.5% | Maxim Group | → $3 | Initiates Coverage On | → Buy |
| 02/02/2022 | 488.54% | Brookline Capital | → $5.65 | Initiates Coverage On | → Buy |
| 09/22/2021 | 1410.42% | Alliance Global Partners | → $14.5 | Initiates Coverage On | → Buy |
What is the target price for Icecure Medical (ICCM)?
The latest price target for Icecure Medical (NASDAQ: ICCM) was reported by HC Wainwright & Co. on August 15, 2023. The analyst firm set a price target for $3.00 expecting ICCM to rise to within 12 months (a possible 212.50% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Icecure Medical (ICCM)?
The latest analyst rating for Icecure Medical (NASDAQ: ICCM) was provided by HC Wainwright & Co., and Icecure Medical reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Icecure Medical (ICCM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Icecure Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Icecure Medical was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
Is the Analyst Rating Icecure Medical (ICCM) correct?
While ratings are subjective and will change, the latest Icecure Medical (ICCM) rating was a reiterated with a price target of $0.00 to $3.00. The current price Icecure Medical (ICCM) is trading at is $0.96, which is within the analyst's predicted range.